Human cells derived from both normal and neoplastic tissues can be infected by Mason-Pfizer monkey virus (MPMV) without accompanying cytopathology. Infection of cell cultures such as human rhabdomyosarcoma (A2o4) results in a persistently infected cell line which can be subcultured over 3o sequential culture passages without significant change in phenotypic properties according to reverse, transcriptase (RT), MPMV p27 antigen content, virus particle count and infectivity titrel Productive virus infections were established at relatively low virus particle (VP) input multiplicities (p.i.m. ; about o.o6 VP/cell) in A2o4 cell cultures. At higher p.i.m. (about 6oo to 6ooo VP/cell) newly synthesized virus was detected within 4 days post infection. Although virus production was cumulative following primary infection, after subculture of infected cultures MPMV production was greater during active cell division. Using synchronization techniques, MPMV replication in persistently infected cultures was found to be cell cycle-dependent. The major internal antigen, P27, was synthesized in G2 and newly synthesized virus particles were released predominantly during mitosis and early G1. Colcemid arrest of cells during mitosis inhibited subsequent MPMV release. Consequently, production of extracellular virus depends upon the progression of cells through the mitotic stage. These data, which provided a basic understanding of the virushost relationship that occurs in primate cells productively infected with MPMV, were used as a guideline for isolating MPMV-like viruses from experimentally and naturally infected Rhesus monkeys.
INTRODUCTION
The Mason-Pfizer monkey virus (MPMV) first isolated from a breast carcinoma of a female Rhesus monkey (Chopra & Mason, 197o; Jensen et aL 197o) is the prototype of the D group of reverse transcriptase (RT)-containing retroviruses. Subsequent isolates (Ahmed et al. 1974 ) of viruses indistinguishable from MPMV (Colcher et al. 1976; Yeh et al. ~975) have been made from normal tissues of other Rhesus monkeys. Approximately 20 ~o of the MPMV genome is present in the DNA of all tissues of normal Rhesus monkeys (Drohan et al. I977) , whereas the entire MPMV genome can be found in tissues of MPMVinfected monkeys (Colcher et al. 1975 )-These latter findings were the first to suggest that MPMV is a horizontally transmitted virus in macaque species. Other MPMV antigenically related retroviruses (Colcher et al. I977; Hino et al. I977; Devare et al. I978; Fine et al. 1978b ) have been isolated from both a langur monkey (an Old World monkey; Todaro et al. I978 ) and squirrel monkeys (a New World monkey; Heberling et al. 1977) . These retroviruses, which have been identified in several primate populations, appear in many species as complete endogenous proviral DNA sequences (Benveniste & Todaro, I977; Drohan et al. I977; Fine et al. I978b; Schochetman & Fine, 1978 ) .
Earlier studies (Fine et al. I972; Fine et al. 1975) showed that MPMV is infectious for Rhesus monkeys. Virus isolation studies have also shown the presence of infectious virus in saliva and milks of some MPMV-infected rhesus monkeys (Bogden et aL 1978) . These experimentally infected animals develop lifelong immune responses (Devare et al. 1978; Fine & Arthur, 1978) . In examining various primate species for naturally occurring immunity to MPMV, we found that a relatively large proportion of Old World monkeys had antibodies that precipitated MPMV (Fine & Arthur, 1978; Fine et al. I978a; Fine & Schochetman, 1978 ) . Naturally occurring antibodies to MPMV, like those that are experimentally induced, persist throughout the life of the animal. These findings not only support the concept that MPMV is a horizontally transmitted virus in macaque species but also suggest that susceptible primates become persistently infected with MPMV or MPMV-Iike viruses under either experimental or natural conditions.
Although MPMV is infectious for cells of both human and non-human primate origin (Bryant et al. I978; Fine & Schochetman, I978), we do not understand how infectious the virus is nor whether viral persistence is a common feature of MPMV infections. Furthermore, it is not known what existing cell regulatory factors control virus expression. We have attempted to answer these questions by studying the infection and replication of MPMV in human cell cultures and have shown that cell cycle-related expression may be one of the key features of persistent infection with MPMV. Finally, we have demonstrated, through the recovery of MPMV from an animal that was experimentally infected 6 years previously, that MPMV develops persistent infections in vivo.
METHODS

Cells.
The human rhabdomyosarcoma cell line (A2o4) described by Giard et al. (1973) was originally received from Dr G. Todaro, National Cancer Institute. The cultures were free of mycoplasma under both aerobic and anaerobic conditions (Mr R. Del Guidice, FCRC), confirmed to be of human origin and did not contain HeLa cell markers (Dr W. Nelson-Rees, NBRL, Oakland, Calif.). Kirsten murine sarcoma virus-infected human osteosarcoma ceils (TE85/KiMSV; Klement et al. 197 I) were provided by Dr H. Charman, FCRC. The human carcinosarcoma line, HS578T (Hackett et al. I977), was provided by Dr A. Hackett, Palo Alto, Calif. AVa cells were purchased from Flow Laboratories, Rockville, Md. The AVa cells, originally derived from human amnion, contained chromosomal markers characteristic of HeLa cells (Nelson-Rees et al. 1974; Nelson-Rees, 1977) . We refer to these as AVa/HeLa. HeLa cells were originally from a human cervical carcinoma (Gey et al. I952) .
Medium. All cells were grown in 75 cm2 or 15o cm 2 flasks (Corning) at seeding densities of 2×1o 6 cells/flask using RPMI-I64o medium containing lO~ heat-inactivated foetal bovine serum and antibiotics (penicillin ioo units/ml, streptomycin IOO/,g/ml, fungisone o'25/~g/ml and tylosine 60/zg/ml). This medium will hereafter be referred to as culture medium.
Virus. MPMV propagated in cultures of Rhesus monkey mammary tumour and Rhesus monkey embryo (CMMT) cells (Ahmed et al. 197I ) was used for infectivity studies. Human lymphoblastoid (NC37)-derived MPMV was used in MPMV-p27 competition radioimmune assays. Aao4-derived MPMV was labelled with ~25I using lactoperoxidase catalysed iodination (Cardiff, i973) .
Cell monolayers were infected with MPMV diluted in culture medium containing polybrene (z #g/ml). After adsorption at 25 °C for I"5 h, the residual inoculum was removed and the monolayer was washed once with culture medium. Cultures were fed with z5 ml of culture medium and incubated at 37 °C.
Animal tissues. Tissues for virus isolation were from MPMV-inoculated and normal breeding female monkeys housed at Litton Bionetics, Inc., Kensington, Md. (Fine et al. I975) .
Cell synchrony. MPMV-infected Azo4 cell cultures were synchronized by double thymidine block using essentially those procedures outlined by Panem & Kirsten (I973) . Cells were also synchronized with colcemid (Grand Island Biological, Grand Island, N.Y.) at a final concentration of o'o3 #g/ml in culture medium. Ceils were allowed to accumulate in metaphase for 24 h at 37 °C prior to release. Release was accomplished by gently washing the monolayers twice with PBS, then adding fresh culture medium (z5 °C). Approximately 85 ~ synchronization with minimum cell death was achieved by colcemid block, as indicated by viable cell counts using trypan blue.
Mitotic indices were determined on synchronized cells by resuspending the cell pellets in o-6 ~ (w/v) sodium citrate. The suspensions were gently agitated for 2o rnin and centrifuged at 35 g for 5 min, the supernatant was withdrawn and the pellets were fixed with z to 3 ml of Carnoy's fixative. The supernatant was removed and the cell pellet was resuspended for Io rain in i.o ml bisbenzamide stain (o.o 5 #g/ml). The stained cells were then centrifuged at 35 g for 5 rain, the supernatant was removed and the cell pellet was resuspended in PBS/glycerol mixture (I : t, v/v) and placed directly on to a glass microscope slide. All steps were performed at 4 °C. Cells were observed under u.v. microscope and the number of mitotic figures which appeared in Ioo cells determined. Cell DNA synthesis was measured by the protocol described by Ashkenazi-Ezra & Ashkenazi (I976). Elapsed time between peaks of 3H-deoxy thymidine (3H-dThd) incorporation in cells synchronized by double thymidine block and cell counts showed the doubling time for Azo4 cells to be 2o to 2z h. This was slightly less than the time required for >~ 85 ~ of the colcemic-treated cells to complete the cell cycle and become arrested at metaphase (24 h). Cell cycle and duration were defined as follows: S phase, time of incorporation of 3H-dThd after release from double thymidine block (74-I h); G2 phase, time between decrease in 3H-dThd incorporation and increase in mitotic figures (3-4-I h); M phase, time required for cells to go through mitosis (2=kI h); G1 phase, time required to begin incorporation of 3H-dThd after release from colcemid arrest. Portions of these data are represented in Fig. I and 2 .
Virus assays. The RT assay consisted of a Mg 2 +-dependent test employing oligo (dG). poly (rC) exogenous template (Fine et al. I974) . The indirect immunofluorescence assay was detailed previously (Fine et al. ~974) .MPMV antigens were also quantified using a previously described radioimmune assay for MPMV p27 (Schochetman et al. I977) .
Intact virus radioimmune precipitation (RIP) assays for MPMV antibodies were performed by incubating lzSI-MPMV (~5ooo to zoooo ct/min) with diluted monkey sera for I h at 37 °C. Goat anti-monkey IgG (diluted I : 5) was added and incubation continued at 37 °C for I h and overnight at 4 °C. All dilutions were made in RIP buffer (o.ol M-tris-HC1, pH 7"4; o'or M-NaCI; and o.oox M-EDTA). After incubation, I ml of RIP buffer was added and the immune precipitates were collected by centrifuging at a5oo g for 3o min. Supernatants were aspirated and the radioactivity in the immune pellets was determined.
The KC cell infectivity assay for MPMV was performed as described by Rand et al. (1974) .
Virus particles were quantified by electron microscopy according to the method of Monroe & Brandt (r97o) . Number of virus particles per ml (VP/ml) in undiluted virus concentrates was used in conjunction with number of cells per culture flask to calculate virus p.i.m. Protein in virus suspensions was determined by the procedure of Lowry et al. (I95I) using bovine serum albumin as a standard.
RESULTS
Replication of MPMV in human cell cultures
Earlier studies (Bryant et al. 1978; Fine & Schochetman, ~978) had established that the host range for MPMV is primarily restricted to primate cell cultures, including those of human origin. Furthermore, we had found that a variety of human cells from both primary and continuous cultures established from normal and neoplastic tissues were permissive for MPMV replication (Fine & Schochetman, 1978 ) . In those studies, MPMV replication was based on production of virus RT into extracellular culture fluids. Because of the variable cell growth of the respective cell cultures, levels of virus RT were compared on a per cell basis. The highest levels of virus RT were produced from A2o4, TE85/KiMSV, AVa (HeLa) and HS578T cell cultures. These four human cell lines were each derived from neoplastic tissue. One of these, the A2o4 cell line, was used for studying kinetics of MPMV replication because the cell line was most easily propagated in culture and had been previously used as a tissue culture source for production of MPMV (Benton et al. 1978) . Uninfected A2o 4 cells were also previously reported to be free of MPMV-RNA (Parks et al. I973) .
Kinetics of MPMV production
To determine the kinetics of release of newly synthesized virus after infection, replicate A2o4 cell cultures (2× I@ ceils/flask) were exposed to inocula which contained from 6 × to 4 (undiluted virus) to 6 × xo -~ VP/cell (io -a dilution). On days 3 to 7 of the primary infection (P0) and on days 3, 5, and 7 of subsequent passages (P1-4), culture fluids were removed and replaced with fresh culture medium. These fluids were assayed for RT activity. Newly synthesized virus was detectable during P0 from cultures inoculated with about 6 × Io 1 VP/cell. In cultures inoculated with >~ 6 × ro 1 VP/cell virus release as measured by RT activity was detected on day 3 of P0 (Table I) . With each successive day between days 3 and 7 of Po, more virus was produced. Maximum levels of RT were observed in those cultures inoculated with Io q virus dilution (~6× IO a VP/cell). Except for the cultures inoculated with undiluted virus, levels of RT decreased with increasing dilutions of inocula. The dose-response nature of RT expression in P0 cultures appears to be related to the number of cells initially infected. The ability to detect newly synthesized virus within 6 days P0 with p.i.m, as low as 6 × Io ~ VP/cell (io -3 dilution) was remarkable since we had previously found that Rhesus monkey and human embryonic kidney cells that had been inoculated with MPMV at relatively high p.i.m. (5 × Io~ VP/cell) did not express virus antigen or virus RT activity until 9 days p.i. and after one culture passage (Nossik et al. I976) .
Cultures inoculated with ~o -4 to IO 6 virus dilutions did not express RT until after subculturing; nevertheless, it was apparent that productive infection of A2o4 cultures could be accomplished at p.i.m, as low as ~ 6 x Io -2 VP/cell. These observations were consistent from experiment to experiment and within triplicate cultures of individual experiments. In this and subsequent titrations, the endpoint for productive infection was established by the fourth successive passage of the infected cultures. Cultures inoculated with virus dilutions beyond the RT infectivity endpoint were negative after an additional three passages. Based on RT activity, the endpoint titres for MPMV infectivity in A2o4 cells were equivalent to those achieved in infected human NC37 cells (courtesy of Dr M. Ahmed, Pfizer, Inc., Maywood, N.J.). Infectivity titres of CMMT-derived MPMV in A2o4 cells when compared with the KC syncytia titre were generally found to differ by approx. 2 log10 units/ml. With passage of the infected A2o4 cultures, increasingly higher levels of RT activity were observed over four to five passages, after which virus production stabilized. In these 'productively' infected cultures, the RT activity level and virus particle count averaged 2025 pmol/ml/h and 1.4 × to1° VP/ml, respectively. Approximately 75~ of the A2o4 cells Table I .
Virus production in fluids of MPMV-infected A2o4 cultures with respect to virus dilution and time (days, passages) after infection
Reverse transcriptase activity (pmot/ml/h)*,'~ at P4 p.i. were positive for virus antigen when tested by fixed immunofluorescence with rabbit anti-MPMV p27 serum, whereas uninfected A2o4 cells were negative. MPMV expression was stable with continuous culture passage. MPMV-infected (p.i.m. 6× Io ~ VP/cell) A2o 4 cells were subcultured at 7-day intervals for I5 passages in three repeat experiments. Culture fluids were collected on day 5 of each culture transfer and assayed for RT, MPMV p27 antigen and virus particle count. Infectivity assays were performed at Ps, P11 and Pls p.i. Based on these assays, persistently infected A2o 4 cells continued to express MPMV at a constant level and the virus was not altered biochemically, antigenically or biologically.
Although MPMV preparations remained infectious for A2o 4 cell cultures after three cycles of freeze-thawing, virus infectivity was destroyed by either u.v.-irradiation or sonication. Preparations (I ml) containing 2×IO 6 median tissue culture infective dose (TCIDs0)/ml of MPMV were rendered non-infectious for A2o4, KC or human embryonic kidney cells after exposure to u.v. light (I7"5 cm × I25o erg/cm ~) for 8 min. A2o4 and human embryonic kidney cells inoculated with u.v. treated virus showed no RT activity three passages after inoculation. Inactivation of MPMV focus induction in KC cell monolayers with u.v. light followed single-hit kinetics. KC focus induction by MPMV (2 × Io 6 TCIDs0/ ml) was destroyed by sonication in serum-free culture medium for I rain at 3o mA (Heat Systems Sonifier Cell Disrupter, Model WI4o).
Cell cycle dependency of MPMV production
In subculturing MPMV-infected A2o 4 cells, we found variable levels of RT in successive 48 h harvests of culture fluid. Virus particle counts showed similar fluctuations. When culture fluids were collected sequentially at 24 h intervals, more virus was produced during days 2 to 4 after subculturing, when cells are actively dividing. These results suggested that replication and/or expression of MPMV in productively infected cells is cell cycle-dependent. To demonstrate that MPMV replication and production in human cell cultures is cell cycle-dependent, A2o4 cells productively infected with MPMV were synchronized by doublethymidine block and colcemid arrest methods. Synchronized cell cultures released from these cell cycle blocks were monitored for DNA synthesis (by uptake of thymidine) and mitosis. Production of virus was measured by RT activity and virus particle counts. Intracellular expression of MPMV antigens was measured by RIA for MPMV pz7. The results of these experiments are shown in Fig. I to 3 .
MPMV-infected A2o 4 cells released from double thymidine block reached maximum DNA synthesis approx. 4 h after release and entered mitosis approx. 8 to IO h after release (Fig. I) . These cultures accumulated detectable levels of cell-associated MPMV p27 antigen between 6 and 8 h after release, which coincided with the G2 phase of the cell cycle. Levels of cell-associated antigen decreased by Io h after release, followed by an accumulation of RT activity in the cell culture fluid between Io and I2 h after release. The highest levels of RT activity coincided with the peak of mitosis and early G1 phases of the cell cycle. Similarly, in colcemid synchronized cultures, the major peak of virus was released in the extracellular fluid between 4 and 6 h after release from metaphase (Fig. 2) . This release coincided with the early G1 phase of the cell cycle. A smaller peak of RT activity was observed io h after release and preceded DNA synthesis, which was maximal I4 h after release.
In the experiments presented in Fig. I and z, release of virus into extracellular fluid correlated with passage of cells through mitosis. Although these data demonstrate that MPMV expression is cell cycle-related, they also suggest that release of MPMV from infected cells is dependent on passage of cells through mitosis. To demonstrate cell cycle-dependence, replicate cultures were arrested at the G1/S interphase by double thymidine block. One set of cultures released from this block was allowed to progress through the cell cycle, whereas the duplicate group was treated with colcemid medium and consequently arrested. In the first group, there were increased levels of virus RT in the extracellular fluids within I h after the peak of mitosis. These levels persisted throughout the next 5 h and coincided with the early G1 phase (Fig. 3) . A second, smaller peak of RT activity was found 18 h after release from double thymidine block. No RT expression was observed in the replicate culture blocked by colcemid. Concentrated culture fluid from the serial harvests were examined for virus particles. Virus was found in the samples collected between 9 and I3 h after release from double thymidine block. This corresponded to the major peak in RT activity. The largest number of virus particles (~ × ios particles/ml) were present I I h post release. Corresponding fluids from colcemid-treated cultures were negative for virus within the limit of detection (>/3"4× IoT/ml)-These results indicate not only that MPMV production is cell cycle-related but also that virus is produced only in those MPMV-infected cells that have passed through mitosis. Inhibition of MPMV production in cells arrested in mitosis appears not to be due to prevention of virus being released from the cell membrane but rather to a limiting step prior to virus maturation. This conclusion was based on examination of thinsectioned cell pellets from synchronized MPMV-infected A2o 4 cells arrested by colcemid treatment. Less than 20 ~o of the colcemid-arrested cells examined at I h intervals between to and I5 h after release from double thymidine block contained budding virus particles. Approximately 6~ of the cells contained type A particles, which are presumed to be intra-cytoplasmic precursors to MPMV (Chopra & Mason, I97O) . Approximately I8 ~o of the cells in corresponding cell pellets that were not colcemid-arrested contained intracytoplasmic A particles. In the same preparations approx. 33 ~ of the cells also contained budding and extracellular virus particles. The demonstration of cell cycle-dependent expression of MPMV in persistently infected human cell cultures may thus represent at least one type of cell regulatory factor which controls virus replication.
Isolation of MPMV-related viruses by co-cultivation with human cell cultures
The results presented above demonstrate the propensity for MPMV to infect human cells in culture and the cell cycle-dependency of MPMV expression. These facts provide an experimental approach for recovery of retroviruses from tissues of virus-infected primates. To demonstrate the feasibility of this approach, tissues were collected from normal and MPMV-inoculated Rhesus monkeys and co-cultivated with A2o4 cell cultures. The cocultivated cultures were subcultured at confluency and the culture fluids were monitored at weekly intervals for Mg ~ +-and Mn 2 +-dependent RT. Cell pellets from cultures showing positive RT activity were analysed by electron microscopy and high speed concentrates of culture fluids were assayed for virus antigens by RIA. The four normal monkeys chosen for this study were selected from a group of 35 Rhesus monkeys from the breeding colony at Litton Bionetics, Inc., Kensington, Maryland. Sera from these 35 normal monkeys had been previously screened for antibody to MPMV using an intact particle RIP assay previously described (Fine et al. I978a) . Two of the normal animals were MPMV antibody-positive and two lacked detectable MPMV antibody. A fifth monkey that had been neonatally inoculated with MPMV infected cells was also used. MPMV-like viruses were recovered from tissues of two animals tested. The first isolate was made from the 68-month-old experimentally infected female Rhesus monkey, B5475. After 4 weeks of cultivation, Mg ~ +-positive RT was observed in spleen and bone marrow cultures. An additional 8 weeks of co-cultivation of brain and heart tissues from the same animal failed to yield positive RT. Both RT-positive cultures had high Mg 2 +/Mn 2+ ratios (8"7 and I I.O, respectively), characteristic of MPMV. MPMV-like particles were also observed by electron microscopy. Virus concentrated from the spleen/A2o4 co-cultivation culture exhibited a KC cell infectivity titre of 6"7 x IO 4 syncytia/ml. The second virus isolation was made from the spleen of one of the four normal Rhesus monkeys after ! 3 weeks of co-cultivation. This 84-monthold female was one of the two MPMV antibody-positive animals selected. The RT of this isolate also had a high Mg 2 +/Mn ~ + ratio (I 1.8). Thin section electron microscopic examination of the spleen/A2o4 co-cultivation culture revealed MPMV-Iike particles. Concentrated fluids from this culture also produced multinucleated syncytia (~-8 x To2/ml) in the KC cell test and competed in the RIA for MPMV p27 antigens. The lymph node, bone marrow, thymus, salivary gland, and peripheral blood lymphocytes from this monkey and corresponding tissues from the other three normal rhesus monkeys were negative for RT activity over a minimum of 23 weeks of co-cultivation. Spleens from all three normal animals were cultured an additional 8 weeks and remained negative (data not shown).
DISCUSSION
These studies provide a detailed characterization of the replication and establishment of persistent infections of MPMV in human cell cultures. In contrast to induction of multinucleated syncytia, which occurs when foetal Rhesus monkey cell cultures are infected by MPMV (Fine et al. I971) , MPMV-infected human cell cultures do not exhibit marked cytopathology or altered cell morphology. Consequently, the presence of the virus can go undetected in human cell cultures. Furthermore, since virus replication appears to be cellcycle dependent, MPMV expression is detectable only in actively dividing cultures and then only with sensitive immunological or biochemical assays. Each of these properties of MPMV replication should be considered in attempts to detect expression of retrovirus or to isolate retrovirus from human tissues. Because productive infections of human cells with MPMV can occur at relatively low virus:cell input multiplicities, cross-contamination of human cell cultures with this virus is feasible. Consequently, caution should be exercised in handling human cell cultures in laboratories where MPMV or monkey cell cultures are being used.
Based on the cell cycle studies presented here, we know that MPMV p27 antigen is expressed predominantly during the G2 phase and that extracellular virus is subsequently released during late mitosis and the early G1 phases of the cell cycle. We can thus conclude that MPMV synthesis is cell cycle-dependent and that we were not simply observing the virus antigen synthesis which occurred throughout the cell cycle and was preferentially released as mature virus from cells during a specific phase of the cell cycle. Cell cycledependent synthesis of virus antigens thus appears to be under cellular control, which is to be expected in the case of a virus that exists in proviral form in the DNA of the cells it infects. Avian (Humphries & Temin, 1972; Leong et al. 1972) and murine (Panem & Kirsten, I973 ; Panem & Schauf, 1974; Fischinger et al. I975 ; Paskind et al. I975) type C retroviruses exhibit similar cell cycle-related virus expression. Recently, we have observed that type B murine mammary tumour virus (MMTV) has cell cycle-related synthesis of MMTV structural antigens and production of extracellular MMTV (D. L. Fine & G. Schochetman, unpublished data) . Consequently, cell cycle-related virus expression in vitro appears to be a property of retroviruses which may be fundamental to their establishment as 'regulated infections' (Walker, I964) in stable carrier cultures.
Similarly, cell cycle-regulated virus replication may be also fundamental to persistent expression of virus and/or virus antigens in vivo, e.g. some types of persistent infections found in animals horizontally or congenitally infected with retroviruses. Examples of such retroviruses are Visna and Maedi (Harter & Coward, I974) , equine infectious anaemia virus (McGuire & Henson, I973), avian leukosis virus (Rubin et al. 1962) , gibbon ape lymphoma virus (Kawakami et al. I977 ) and bovine leukosis virus (Levy et al. I977) .
Our ability to isolate MPMV-like viruses from tissues of MPMV-infected rhesus monkeys several years after inoculation (Fine et al. I975) , combined with our recent findings of precipitating (Fine et al. I978a ) and neutralizing antibodies to MPMV which persist throughout life in MPMV-infected animals indicate that MPMV can exist as a persistent infection in susceptible primate hosts.
We isolated MPMV virus from the spleen and bone marrow of an animal 68 months after it was inoculated with MPMV-infected cells. During this time the animal remained clinically asymptomatic. Similarly, an MPMV-Iike virus was isolated from the spleen of a 7-year-old, non-inoculated but MPMV antibody-positive, female breeder Rhesus monkey. We were not successful in recovering virus from other organs of the same monkeys. That both isolates were recovered from the spleen suggests that the virus is lymphotropic and consequently recoverable only from the specific target tissues which it infects. Alternatively, our infectivity results indicate that MPMV may have a broad tissue tropism but is most easily recovered from those tissues which have actively dividing cells. Since MPMV expression is cell cycle-related, one would expect virus to be more readily expressed and consequently more easily recovered from rapidly dividing tissues (e.g. placenta, mammary gland, bone marrow and spleen) than from tissues undergoing relatively little cell division (e.g. brain). Previously, MPMV-like viruses were isolated from lactating mammary gland and full-term placenta of other clinically asymptomatic monkeys housed at the Litton Bionetics colony (Ahmed et al. I974) . These alternative hypotheses are testable using in situ nucleic acid hybridization assays for MPMV-DNA and -RNA and radioimmune 
